Beginning in 2024, the FDA expanded Wegovys approval to include reducing cardiovascular risk in adults with existing heart disease
And yet, when you ask the question that matters most, what do we actually know in humans, the answer is uncomfortable
The lowest amount reported lost by bariatric patients was 13 pounds
Additionally, GLP-1 agonists influence gastric emptying, which could interact with psychiatric medication pharmacokinetics, altering their effectiveness or safety, especially those with weight-based dosing
Semaglutide has a finalized Nexus Lab Verified record that reports 99.52% HPLC area-percent purity for the represented batch
Protection from direct light and air exposure